Important miRs of Pathways in Different Tumor Types

PLoS Computational Biology

Volumn 9, Issue 1, 2013, Pages

  Wuchty, Stefan ^a   Arjona, Dolores ^b   Bauer, Peter O ^c,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b GENEDX   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; GAIN LOSS; GENE EXPRESSION CORRELATION; GENE EXPRESSION PROFILES; GLIOBLASTOMAS; MOLECULAR PATHWAYS; OVARIAN CANCERS; PHYSICAL INTERACTIONS;

DISEASES;

MICRORNA; SMALL UNTRANSLATED RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INTERACTION; GENE TARGETING; GLIOBLASTOMA; HUMAN; OVARY CANCER;

EID: 84873508645     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002883     Document Type: Article

References (76)

1. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Martinez NJ, Walhout AJ, (2009) The interplay between transcription factors and microRNAs in genome-scale regulatory networks. Bioessays 31: 435-445.
3. Shalgi R, Lieber D, Oren M, Pilpel Y, (2007) Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3: e131.
4. Wang J, Lu M, Qiu C, Cui Q, (2010) TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res 38: D119-122.
5. Houbaviy HB, Murray MF, Sharp PA, (2003) Embryonic stem cell-specific MicroRNAs. Dev Cell 5: 351-358.
6. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
7. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
8. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
9. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
10. Chen CZ, (2005) MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353: 1768-1771.
11. Hurst DR, Edmonds MD, Welch DR, (2009) Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 69: 7495-7498.
12. Chan E, Prado DE, Weidhaas JB, (2011) Cancer microRNAs: from subtype profiling to predictors of response to therapy. Trends Mol Med 17: 235-243.
13. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.
14. Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, et al. (2008) microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res 68: 3566-3572.
15. Zhang J, Han L, Ge Y, Zhou X, Zhang A, et al. (2010) miR-221/222 promote malignant progression of glioma through activation of the Akt pathway. Int J Oncol 36: 913-920.
16. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
17. Budhu A, Ji J, Wang XW, (2010) The clinical potential of microRNAs. J Hematol Oncol 3: 37.
18. Hammond SM, (2006) MicroRNAs as oncogenes. Curr Opin Genet Dev 16: 4-9.
19. Schickel R, Boyerinas B, Park SM, Peter ME, (2008) MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 27: 5959-5974.
20. Krutovskikh VA, Herceg Z, (2010) Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays 32: 894-904.
21. Wuchty S, Arjona D, Bozdag S, Bauer PO, (2012) Involvement of microRNA families in cancer. Nucleic Acids Res DOI:10.1093/nar/gks627.
22. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA, (2009) MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 9: 293-302.
23. Lu M, Zhang Q, Deng M, Miao J, Guo Y, et al. (2008) An analysis of human microRNA and disease associations. PLoS One 3: e3420.
24. Croft D, O'Kelly G, Wu G, Haw R, Gillespie M, et al. (2011) Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res 39: D691-697.
25. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat Genet 37: 495-500.
26. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
27. Enright AJ, John B, Gaul U, Tuschl T, Sander C, et al. (2003) MicroRNA targets in Drosophila. Genome Biol 5: R1.
28. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
29. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, et al. (2011) Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS One 6: e14681.
30. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
31. Breiman L, (2001) Random Forests. Machine Learning 45: 5-32.
32. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 57: 289-300.
33. Wuchty S, (2004) Evolution and topology in the yeast protein interaction network. Genome Res 14: 1310-1314.
34. Sethupathy P, Megraw M, Hatzigeorgiou AG, (2006) A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 3: 881-886.
35. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H, (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 104: 15472-15477.
36. Zhang J, Han L, Ge Y, Zhou X, Zhang A, et al. (2010) miR-221/222 promote malignant progression of glioma through activation of the Akt pathway. Int J Oncol 36: 913-920.
37. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, et al. (2009) microRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69: 7569-7576.
38. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, et al. (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752.
39. He L, He X, Lim LP, de Stanchina E, Xuan Z, et al. (2007) A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
40. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, et al. (2009) MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69: 7569-7576.
41. Phillips-Mason PJ, Kaur H, Burden-Gulley SM, Craig SE, Brady-Kalnay SM, (2011) Identification of phospholipase C gamma1 as a protein tyrosine phosphatase mu substrate that regulates cell migration. J Cell Biochem 112: 39-48.
42. Chen L, Li H, Han L, Zhang K, Wang G, et al. (2011) Expression and function of miR-27b in human glioma. Oncol Rep 26: 1617-1621.
43. Guerau-de-Arellano M, Smith KM, Godlewski J, Liu Y, Winger R, et al. (2011) Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity. Brain 134: 3578-3589.
44. Kuehbacher A, Urbich C, Dimmeler S, (2008) Targeting microRNA expression to regulate angiogenesis. Trends Pharmacol Sci 29: 12-15.
45. Urbich C, Kuehbacher A, Dimmeler S, (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588.
46. Cui JG, Zhao Y, Sethi P, Li YY, Mahta A, et al. (2010) Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. J Neurooncol 98: 297-304.
47. Xia H, Qi Y, Ng SS, Chen X, Chen S, et al. (2009) MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells. Biochem Biophys Res Commun 380: 205-210.
48. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14.
49. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
50. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, et al. (2008) MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28: 5369-5380.
51. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, et al. (2007) MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67: 8994-9000.
52. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283: 1026-1033.
53. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
54. Zhu S, Wu H, Wu F, Nie D, Sheng S, et al. (2008) MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.
55. Sumara I, Vorlaufer E, Gieffers C, Peters BH, Peters JM, (2000) Characterization of vertebrate cohesin complexes and their regulation in prophase. J Cell Biol 151: 749-762.
56. Haering CH, Farcas AM, Arumugam P, Metson J, Nasmyth K, (2008) The cohesin ring concatenates sister DNA molecules. Nature 454: 297-301.
57. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
58. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, et al. (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333: 1039-1043.
59. Dupressoir A, Morel AP, Barbot W, Loireau MP, Corbo L, et al. (2001) Identification of four families of yCCR4- and Mg2+-dependent endonuclease-related proteins in higher eukaryotes, and characterization of orthologs of yCCR4 with a conserved leucine-rich repeat essential for hCAF1/hPOP2 binding. BMC Genomics 2: 9.
60. Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, et al. (2007) Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell 18: 4543-4552.
61. Mittal S, Aslam A, Doidge R, Medica R, Winkler GS, (2011) The Ccr4a (CNOT6) and Ccr4b (CNOT6L) deadenylase subunits of the human Ccr4-Not complex contribute to the prevention of cell death and senescence. Mol Biol Cell 22: 748-758.
62. Sanchez-Perez I, Manguan-Garcia C, Menacho-Marquez M, Murguia JR, Perona R, (2009) hCCR4/cNOT6 targets DNA-damage response proteins. Cancer Lett 273: 281-291.
63. Li Y, Zhao S, Zhen Y, Li Q, Teng L, et al. (2011) A miR-21 inhibitor enhances apoptosis and reduces G(2)-M accumulation induced by ionizing radiation in human glioblastoma U251 cells. Brain Tumor Pathol 28: 209-214.
64. Yamashita Y, Kasugai I, Sato M, Tanuma N, Sato I, et al. (2010) CDC25A mRNA levels significantly correlate with Ki-67 expression in human glioma samples. J Neurooncol 100: 43-49.
65. Zahler AM, Lane WS, Stolk JA, Roth MB, (1992) SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev 6: 837-847.
66. Jia R, Li C, McCoy JP, Deng CX, Zheng ZM, (2010) SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int J Biol Sci 6: 806-826.
67. Annovazzi L, Mellai M, Caldera V, Valente G, Schiffer D, (2011) SOX2 expression and amplification in gliomas and glioma cell lines. Cancer Genomics Proteomics 8: 139-147.
68. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, et al. (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
69. Sampson VB, Rong NH, Han J, Yang Q, Aris V, et al. (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67: 9762-9770.
70. Lee ST, Chu K, Oh HJ, Im WS, Lim JY, et al. (2011) Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J Neurooncol 102: 19-24.
71. Kim JH, Zheng LT, Lee WH, Suk K, (2011) Pro-apoptotic role of integrin beta3 in glioma cells. J Neurochem 117: 494-503.
72. Reimer D, Hubalek M, Kiefel H, Riedle S, Skvortsov S, et al. (2011) Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancer. Oncogene 30: 4038-4049.
73. Hagopian JC, Ma CT, Meade BR, Albuquerque CP, Ngo JC, et al. (2008) Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1. J Mol Biol 382: 894-909.
74. Park JK, Henry JC, Jiang J, Esau C, Gusev Y, et al. (2011) miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem Biophys Res Commun 406: 518-523.
75. Aqeilan RI, Calin GA, Croce CM, (2010) miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17: 215-220.
76. Wang Y, Yu Y, Tsuyada A, Ren X, Wu X, et al. (2011) Transforming growth factor-beta regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene 30: 1470-1480.